Are you looking to enhance your immunoassay development techniques by working for a global pharmaceutical company that allows you to leverage best in class systems and technologies? If so, this Immunoassay Investigator role is the ideal opportunity for you.
We are looking for a highly motivated, flexible and experienced scientist to join a team within the Bioanalysis, Immunogenicity and Biomarkers (BIB) department based in our Upper Providence, PA location.
As an Immunoassay Investigator, you will be responsible for the development, validation and sample analysis of PK assays for use in pre-clinical PK/PD/modelling studies and translation into the clinic in alignment with therapy area partners. Data from this group is a key component to understanding molecules in the GSK pipeline; and serves to make early and informed decisions for asset progression within the organization.
This role will provide you the opportunity to lead key activities to progress your career, these responsibilities include some of the following:
Why you? Basic Qualifications:
- Responsible for developing bespoke assays to support pre-clinical and clinical studies; delivery of robust, high quality data packages and will demonstrate the ability to critique work to enable lead modalities to be smoothly progressed into clinical development.
- Independently providing sample analysis support for non-clinical and clinical studies by delivering high quality data packages working in a GLP/GCP compliant laboratory setting.
- Deliver, interpret and communicate complex scientific data to project/program teams in a timely manner by performing data analysis, record keeping and reporting of results to agreed timelines.
- Works and communicates effectively with the group and speaks up when necessary.
- Contribute to departmental strategy and capital investment discussions.
- Handling of human biological samples and performing experimental work in accordance with HBSM, safety and data integrity guidelines.
We are looking for professionals with these required skills to achieve our goals:
- PhD in Biology, Biochemistry, Immunology or related discipline or BS/MS with >3 years of experience in a regulated pharmaceutical or biotechnology environment with a thorough understanding of the drug development process.
- 3+ years experience with hands-on laboratory experience and theoretical understanding of non-clinical and clinical immunoassay development, validation and study support for either PK or biomarker (ELISA/MSD/Singulex/Gyros).
- Proven ability to provide translational expertise on programs/project teams for pre-clinical and clinical studies with a wide variety of techniques and technologies.
If you have the following characteristics, it would be a plus:
- Maintains a disciplined approach, ensuring a relentless focus on quality, compliance, scientific rigor and operational excellence.
- Attention to detail and good communication and documentation skills will be expected.
- Highly motivated team player with a proactive attitude, excellent organizational skills and a demonstrated ability to interact effectively within a multi-disciplinary team are essential.
- Strong publication/presentation history
- Biomarker experience is a plus.
We're uniting science, technology and talent to make a difference in more people's lives, and revolutionising the way we do R&D.
We're combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why. We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.
No single scientist, nor any one technology can keep us all ahead of disease. That's why we build important collaborations with commercial and academic partners to advance our understanding of disease and what it takes to get ahead. In the past three years, we've doubled the number of partnerships we've signed, because of our belief in their significant impact on our process.
Our pipeline currently comprises of more than 60vaccines and medicines across four core therapeutic areas including infectious diseases, HIV, oncology and immunology as well at pursuing other science-led opportunities outside our core areas. Many have the potential to be first or best-in-class opportunities for patients and since 2017, we've delivered 13 major approvals and more than doubled the number of potential new vaccines and medicines in Phase 3 and registration to 23.
In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude , our new long-acting medicine for HIV prevention.
We give our scientists the freedom to own the process. Our scientists often use genetic data to help us understand the root cause of disease. We steer the research where the data shows we can do the most good . If a project doesn't pan out, we take what we've learned and apply it elsewhere.
Find out more: Our approach to R&D
. *LI-GSK #WYARD2022
If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US).
GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
At GSK, the health and safety of our employees are of paramount importance. As a science-led healthcare company on a mission to get ahead of disease together, we believe that supporting vaccination against COVID-19 is the single best thing we can do in the US to ensure the health and safety of our employees, complementary workers, workplaces, customers, consumers, communities, and the patients we serve.
GSK has made the decision to require all US employees to be fully vaccinated against COVID-19, where allowed by state or local law and where vaccine supply is readily available. The only exceptions to this requirement are employees who are approved for an accommodation for religious, medical or disability-related reasons.Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit GSK's Transparency Reporting For the Record